Immune PET Imaging

被引:3
作者
Iyalomhe, Osigbemhe [1 ]
Farwell, Michael D. [1 ]
机构
[1] Univ Penn, Dept Radiol, 3400 Spruce St, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
Immunotherapy; Immune-related adverse events; FDG; PET/CT; Immune imaging; METASTATIC MELANOMA PATIENTS; RESPONSE CRITERIA; F-18-FDG PET/CT; PD-1; BLOCKADE; CHECKPOINT INHIBITOR; ANTITUMOR IMMUNITY; CLINICAL-RESPONSE; TUMOR RESPONSE; ADVERSE EVENTS; CANCER;
D O I
10.1016/j.rcl.2021.05.010
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
[No abstract available]
引用
收藏
页码:875 / 886
页数:12
相关论文
共 101 条
[51]   Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance [J].
Martins, Filipe ;
Sofiya, Latifyan ;
Sykiotis, Gerasimos P. ;
Lamine, Faiza ;
Maillard, Michel ;
Fraga, Montserrat ;
Shabafrouz, Keyvan ;
Ribi, Camillo ;
Cairoli, Anne ;
Guex-Crosier, Yan ;
Kuntzer, Thierry ;
Michielin, Olivier ;
Peters, Solange ;
Coukos, Georges ;
Spertini, Francois ;
Thompson, John A. ;
Obeid, Michel .
NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (09) :563-580
[52]   Detection of immune-related adverse events by medical imaging in patients treated with anti-programmed cell death 1 [J].
Mekki, Ahmed ;
Dercle, Laurent ;
Lichtenstein, Philip ;
Marabelle, Aurelien ;
Michot, Jean-Marie ;
Lambotte, Olivier ;
Le Pavec, Jerome ;
De Martin, Eleonora ;
Balleyguier, Corinne ;
Champiat, Stephane ;
Ammari, Samy .
EUROPEAN JOURNAL OF CANCER, 2018, 96 :91-104
[53]  
Meller J, 2007, J NUCL MED, V48, P35
[54]  
MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO
[55]  
2-6
[56]   Systemic Immune Response to Vaccination on FDG-PET/CT [J].
Mingos M. ;
Howard S. ;
Giacalone N. ;
Kozono D. ;
Jacene H. .
Nuclear Medicine and Molecular Imaging, 2016, 50 (4) :358-361
[57]   Nivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial [J].
Motzer, Robert J. ;
Rini, Brian I. ;
McDermott, David F. ;
Redman, Bruce G. ;
Kuzel, Timothy M. ;
Harrison, Michael R. ;
Vaishampayan, Ulka N. ;
Drabkin, Harry A. ;
George, Saby ;
Logan, Theodore F. ;
Margolin, Kim A. ;
Plimack, Elizabeth R. ;
Lambert, Alexandre M. ;
Waxman, Ian M. ;
Hammers, Hans J. .
JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (13) :1430-1437
[58]   Prognostic Value of Bone Marrow Metabolism on Pretreatment 18F-FDG PET/CT in Patients with Metastatic Melanoma Treated with Anti-PD-1 Therapy [J].
Nakamoto, Ryusuke ;
Zaba, Lisa C. ;
Liang, Tie ;
Reddy, Sunil Arani ;
Davidzon, Guido ;
Aparici, Carina Mari ;
Nguyen, Judy ;
Moradi, Farshad ;
Iagaru, Andrei ;
Franc, Benjamin Lewis .
JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (10) :1380-1383
[59]   Pembrolizumab-Induced Thyroiditis and Colitis-Presentation and Resolution on Serial FDG PET/CT [J].
Nawwar, Ayah Adel ;
Searle, Julie ;
Lyburn, Iain Douglas .
CLINICAL NUCLEAR MEDICINE, 2021, 46 (02) :E121-E122
[60]   PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma [J].
Nghiem, Paul T. ;
Bhatia, Shailender ;
Lipson, Evan J. ;
Kudchadkar, Ragini R. ;
Miller, Natalie J. ;
Annamalai, Lakshmanan ;
Berry, Sneha ;
Chartash, Elliot K. ;
Daud, Adil ;
Fling, Steven P. ;
Friedlander, Philip A. ;
Kluger, Harriet M. ;
Kohrt, Holbrook E. ;
Lundgren, Lisa ;
Margolin, Kim ;
Mitchell, Alan ;
Olencki, Thomas ;
Pardoll, Drew M. ;
Reddy, Sunil A. ;
Shantha, Erica M. ;
Sharfman, William H. ;
Sharon, Elad ;
Shemanski, Lynn R. ;
Shinohara, Michi M. ;
Sunshine, Joel C. ;
Taube, Janis M. ;
Thompson, John A. ;
Townson, Steven M. ;
Yearley, Jennifer H. ;
Topalian, Suzanne L. ;
Cheever, Martin A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26) :2542-2552